Sponsored by:

Nuclear Medicine: Page 386

Hermes taps Howell to lead U.K. unit
Hermes Medical Solutions has tapped Stewart Howell as general manager for U.K. operations, and business development for its Nuclear Diagnostics U.K. company.
March 14, 2004
Myocardial perfusion imaging shows promise in first-time heart failure
By Jerry Ingram
NEW ORLEANS - Myocardial-gated SPECT could play a role in the early evaluation of patients experiencing their first episode of heart failure, according to a poster presented today at the American College of Cardiology meeting.
March 8, 2004
2004 03 08 15 53 09 706
Resting MCE may prove superior to SPECT for identifying myocardial viability
By Jerry Ingram
NEW ORLEANS - Resting myocardial contrast echocardiography (MCE), a new bedside procedure that can determine microvascular perfusion, might one day replace 99mTechnetium sestamibi SPECT for the diagnosis of myocardial viability following acute myocardial infarction, according to a poster presented today at the American College of Cardiology (ACC) meeting.
March 6, 2004
Kereos, Bristol-Myers Squibb to collaborate in molecular imaging
By AuntMinnie.com staff writers
Bristol-Myers Squibb Medical Imaging of North Billerica, MA, and Kereos of St. Louis, MO, have entered into agreements for the development and commercialization of molecular imaging agents.
March 2, 2004
MDS Nordion offers new radioisotopes
By AuntMinnie.com staff writers
Canadian radioisotope supplier MDS Nordion of Kanata, ON, is now offering commercially available rhenium-186 (Re-186) and high-specific-activity lutetium-177 (Lu-177).
March 1, 2004
DraxImage gets FDA OK for skeletal imaging kit
By AuntMinnie.com staff writers
Radiopharmaceutical provider DraxImage has received Food and Drug Administration approval to produce and market a new formulation to prepare a skeletal imaging agent used to demonstrate areas of altered osteogenesis, or bone growth.
February 29, 2004
NAS revenues slip in Q1
By AuntMinnie.com staff writers
Radiopharmaceutical developer North American Scientific reported first-quarter net sales of $3.4 million, down 35% compared with the $5.1 million in sales posted last year.
February 25, 2004
Molecular Imaging revenues up in Q2, but loss widens
By AuntMinnie.com staff writers
PET services provider Molecular Imaging reported unaudited fiscal second-quarter service revenues of $5.6 million, up 10.5% compared with the $5.1 million turned in during the same quarter a year ago.
February 17, 2004
PETNet renews Merck agreement
By AuntMinnie.com staff writers
PETNet Solutions of Knoxville, TN, has renewed an agreement with Merck in which PETNet provides PET research isotopes to the pharmaceutical company.
February 11, 2004
Agenix readies IND application for ThromboView
By AuntMinnie.com staff writers
Australian pharmaceutical developer Agenix is preparing to submit an investigational new drug (IND) application for its ThromboView radiopharmaceutical to the Food and Drug Administration in the second quarter.
February 11, 2004
Digirad launches new OptiCount collimator
By AuntMinnie.com staff writers
Nuclear medicine vendor Digirad has released OptiCount, a collimator that increases the organ sensitivity of its nuclear cardiology gamma cameras by an average of 15% per detector head.
February 10, 2004
Draxis Q4 and year-end revenues jump
By AuntMinnie.com staff writers
Radiopharmaceutical firm Draxis Health enjoyed strong growth in revenues for its fourth quarter and 2003 fiscal year.
February 5, 2004
Previous Page
Page 386 of 440
Next Page